S
Sven Skog
Researcher at Karolinska Institutet
Publications - 79
Citations - 2202
Sven Skog is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Thymidine kinase 1 & Cell cycle. The author has an hindex of 24, co-authored 72 publications receiving 2082 citations. Previous affiliations of Sven Skog include Karolinska University Hospital & Novum.
Papers
More filters
Journal ArticleDOI
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits.
TL;DR: The level of protein M1 was determined by use of a two-site monoclonal antibody-enzyme immunoassay and found to be constant throughout the cell cycle in bovine kidney MDBK cells and the half-life of this subunit was 15 h, contrasting with previous results demonstrating an S-phase-correlated increase in the concentration.
Journal ArticleDOI
Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis.
TL;DR: Pulse-chase experiments with deuterated tyrosine showed unequivocally that the S phase-correlated increase in radical-containing M2 subunit was due to de novo protein synthesis, which is clearly different from the one responsible for regulating protein M2 activity during the cell cycle.
Journal ArticleDOI
S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs.
TL;DR: This paper has used antisense RNA probes in a solution hybridization assay to measure the levels of R1 and R2 mRNA during the cell cycle in centrifugally elutriated cells and in cells synchronized by isoleucine or serum starvation.
Journal ArticleDOI
Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro
TL;DR: Exretion of 8-oxo-dG after in vitro irradiation of whole blood and isolated lymphocytes with clinically relevant doses is reported, and it is found that this excretion is dependent on dose and individual repair capacity, and that it saturates above doses of 0.5–1 Gy of gamma radiation.
Journal Article
Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer.
Qimin He,Tommy Fornander,Hemming Johansson,Ulla Johansson,Guo Zhu Hu,Lars Erik Rutqvist,Sven Skog +6 more
TL;DR: The results indicate that the S-TK1 concentration is higher in patients developing distant and/or loco-regional recurrence 3 months post-surgery.